Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered Biomimetic Nanorobots Orchestrate Targeted Nose-to-Brain Delivery to Resolve Neuron-Glia Entanglement against Parkinson's Disease.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Effect and Mechanism of Cerebrovasodilation Induced by Total Flavonoids of Chuzhou Chrysanthemum in Rats.

Chinese journal of integrative medicine·2025
Same author

[Clinical Analysis of CD4<sup>+</sup>CD8<sup>-</sup> T-Cell Large Granular Lymphocytic[JP] Leukemia].

Zhongguo shi yan xue ye xue za zhi·2024
Same author

Severe fever with thrombocytopenia syndrome complicated by haemophagocytic lymphohistiocytosis: a retrospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024
Same author

Student Loss: Towards the Probability Assumption in Inaccurate Supervision.

IEEE transactions on pattern analysis and machine intelligence·2024
Same author

Cryptotanshinone induces apoptosis of activated hepatic stellate cells <i>via</i> modulating endoplasmic reticulum stress.

World journal of gastroenterology·2023

Related Experiment Video

Updated: Jun 14, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Gene therapy for acute liver failure.

Chuan-Long Zhu1, Yu-Wen Li, Ren-Tao Gao

  • 1Department of Infectious Disease, Affiliated Provincial Hospital, Anhui Medical University, Hefei, 230001, China. zhuchuanlong@yahoo.com.cn

Current Gene Therapy
|April 1, 2010
PubMed
Summary

Gene therapy offers a promising new avenue for treating acute liver failure (ALF), a severe condition with high mortality. This review explores key advancements in gene therapy for ALF, including animal models, delivery methods, and therapeutic targets.

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Related Experiment Videos

Last Updated: Jun 14, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Area of Science:

  • Hepatology
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Acute liver failure (ALF) is a critical condition characterized by rapid liver dysfunction.
  • Current treatments like liver transplantation are limited by organ availability and disease progression.
  • High mortality rates necessitate the development of novel therapeutic strategies for ALF.

Purpose of the Study:

  • To review recent advancements in gene therapy for acute liver failure.
  • To highlight critical technical elements for successful gene therapy in ALF.
  • To discuss potential gene targets for ALF treatment.

Main Methods:

  • Review of current literature on gene therapy for ALF.
  • Focus on animal models used in ALF gene therapy research.
  • Analysis of gene delivery vehicles and techniques.
  • Identification of potential therapeutic gene targets.

Main Results:

  • Gene therapy presents a promising alternative for ALF treatment.
  • Success in gene therapy hinges on appropriate animal models, effective delivery systems, and precise gene targeting.
  • Ongoing research is identifying novel targets and refining delivery methods.

Conclusions:

  • Gene therapy holds significant potential for treating acute liver failure.
  • Further development in delivery technology and target identification is crucial.
  • Advancements in gene therapy could improve outcomes for ALF patients.